Labelling cosmetics in the US: a worked lip balm label and the MoCRA obligations
Every required element on a 4.25 g lip balm label, then the MoCRA obligations with dates and status, the small business exemption and its exclusions.
Cosmetic labelling in the United States is less demanding than most makers fear and more demanding than most makers do. The core rules have been stable since the Fair Packaging and Labeling Act and 21 CFR 701, and they fit on one side of a page. What changed is everything around the label: the Modernization of Cosmetics Regulation Act of 2022, signed on 29 December 2022, added registration, listing, safety substantiation, adverse event reporting and a new label element, and it is still being rolled out.
A US cosmetic label needs a statement of identity and net quantity on the front panel, plus the name and place of business, the ingredient declaration in descending order down to one percent, and contact information for adverse event reports. MoCRA adds registration, listing, safety records and reporting, with a small business exemption from two of those.
Trebalm is a reference site, not a law firm, and this page is orientation rather than legal advice. MoCRA is still being implemented, two of its required rulemakings are overdue, and enforcement positions can change without a change in the statute. Rules also differ by state and by country. Check the current text before you print anything, and take advice if the answer matters commercially. Last checked 6 September 2026.
The anatomy of a label, worked on a 4.25 g lip balm
Take the standard twist-up tube, nominal fill 0.15 oz or 4.25 g. The wrap label on a round 16.5 mm tube is roughly 52 mm around and 45 mm tall, about 23 cm2 or 3.6 square inches of printable surface. For a cylinder the principal display panel is 40 percent of height times circumference, so the "front" is about 1.4 square inches. Every required element still has to fit somewhere on the package.
| Element | Where | Worked wording and the rule |
|---|---|---|
| Statement of identity | Principal display panel | "Lip Balm" or "Beeswax Lip Balm". Common or usual name, bold, in a size reasonably related to the most prominent printing (21 CFR 701.11) |
| Net quantity of contents | Principal display panel | "Net Wt 0.15 oz (4.25 g)". Avoirdupois weight for solids, metric alongside it. Normally in the bottom 30 percent of the panel, waived where the panel is 5 square inches or less (21 CFR 701.13) |
| Name and place of business | Any information panel | "Made for Trebalm Example Co., 1 Example Road, Springfield, IL 62701". Street, city, state and ZIP (21 CFR 701.12) |
| Ingredient declaration | Any information panel | "Ingredients: Ricinus Communis (Castor) Seed Oil, Cera Alba (Beeswax), Butyrospermum Parkii (Shea) Butter, Simmondsia Chinensis (Jojoba) Seed Oil, Tocopherol". Descending order to one percent, letters at least 1/16 inch, or 1/32 inch where the surface is under 12 square inches (21 CFR 701.3) |
| Adverse event contact | Anywhere on the label | A domestic address, a domestic phone number or an electronic contact, which may be a website: "Adverse reactions: example.com/contact". Section 609(a), compliance date 29 December 2024, in force |
| Warnings, if needed | Prominent, bold | Only where necessary to prevent a health hazard, at least 1/16 inch type (21 CFR 740.1 and 740.2) |
| Batch code | Anywhere, often the crimp or base | Not federally required for US cosmetics. Print it anyway: it is the only thing that makes a complaint traceable |
Two details specific to very small packages are worth knowing. Under 12 square inches of surface, the smaller ingredient type size is allowed, and for products sold from a display unit the ingredient declaration may sit in labelling that accompanies the product rather than on the tube. The FDA labelling guide also notes an exemption from the net quantity statement below a quarter of an avoirdupois ounce (7.09 g) where the product is on a display card or in a labelled outer container. A 4.25 g tube is inside that limit, but declare the weight anyway.
Read section 609(a) for its "or". It requires a domestic address, a domestic phone number or an electronic contact for receiving adverse events, and an electronic contact may be a website. Many makers assume they must publish a home phone number, then print one reluctantly or skip the element. A monitored contact page is enough. In force since 29 December 2024.
Ingredient declaration: the rules that trip people up
Ingredients are declared in descending order of predominance. Those above one percent must be in order; those at one percent or less may follow in any order, and colour additives may come after the rest in any order. Products in a shade range may use a "may contain" or "+/-" list of colourants. Trade secret ingredients accepted as exempt may be replaced by "and other ingredients" at the end, which no small maker will ever use, because the exemption has to be granted in advance under 21 CFR 720.8. Incidental ingredients present at insignificant levels with no technical effect do not need declaring.
For an anhydrous product the list is short and unusually honest, because a balm has very little that belongs below one percent. Flavour and sweetener declarations are covered in more detail under lip balm flavour and sweeteners, and if you use essential oils, remember that they are declared by their INCI names, not as "essential oil blend": see essential oils in balms. A buyer's guide to reading the finished result is in reading a balm label.
MoCRA obligations, with dates and current status
MoCRA created duties that sit behind the label rather than on it. The table below is the position as at September 2026, with two of the rulemakings Congress ordered overdue.
| Obligation | Who | Deadline and status |
|---|---|---|
| Facility registration | Owner or operator of a facility that manufactures or processes cosmetics for US distribution | Existing facilities by 29 December 2023, with enforcement deferred to 1 July 2024 by the compliance policy of 9 November 2023. New facilities within 60 days. Renew every two years |
| Product listing | The responsible person, being whoever is named on the label | Same deadline and same enforcement deferral. New products within 120 days of marketing, then updated annually. Free, via Cosmetics Direct or forms FDA 5066 and 5067 |
| Safety substantiation | Everyone, no exemption | In force. Records must support "adequate substantiation of safety", defined as evidence sufficient to support a reasonable certainty that the product is safe |
| Serious adverse event reports | Everyone, no exemption | In force. Report within 15 business days with a copy of the retail label, plus new material medical information for one year afterwards |
| Adverse event records | Everyone | Six years, reduced to three years for a qualifying small business |
| Adverse event contact on the label | Everyone | In force since 29 December 2024. A domestic address, domestic phone number or electronic contact such as a website |
| Professional use labelling | Products for licensed professionals only | In force. Clear and prominent statement that the product is for use by licensed professionals |
| Fragrance allergen labelling | Everyone, once the rule exists | Proposed rule due 18 months after enactment, that is 29 June 2024, not the August 2024 or 29 December 2025 dates that circulate in trade press. Nothing published as at September 2026; projected November 2026. The statute tells the FDA to consider the European Union approach |
| Good manufacturing practice | Everyone except qualifying small businesses | Proposed rule due 29 December 2024 and final rule due 29 December 2025. Both deadlines missed and nothing proposed; projected November 2027. Only a draft guidance exists, and the statute requires simplified requirements for smaller businesses |
Two things there are easy to misread. The statutory deadlines never moved: in November 2023 the FDA deferred enforcement of registration and listing to 1 July 2024, which is a compliance policy, not an extension. And the overdue rulemakings suspend nothing already in force. Scale, for context: the FDA reported 16,398 active facility registrations and 1,298,361 active product listings as at 30 June 2026. This is not a dormant regime.
Two adjacent items are worth a line. The proposed talc testing rule was withdrawn on 28 November 2025. And the FDA's PFAS report of December 2025 found 51 PFAS across 1,744 formulations, 0.41 percent of listed products, with 19 of the top 25 unassessable for want of toxicological data. There is no federal PFAS rule, though several states have their own.
The small business exemption, precisely
Section 612 of the Act, at 21 U.S.C. 364h, says that responsible persons and facility owners "whose average gross annual sales in the United States of cosmetic products for the previous 3-year period is less than $1,000,000, adjusted for inflation" are small businesses and are "not subject to the requirements of section 364b or 364c". Those two sections are good manufacturing practice and registration and listing. Nothing else is exempted.
- Exempt from: facility registration, product listing, and the future GMP regulations.
- Not exempt from: safety substantiation, serious adverse event reporting and records, all labelling requirements, FDA records access, mandatory recall, and every pre-existing rule in 21 CFR 701 and 740.
- Threshold: average gross annual US cosmetic sales under one million dollars over the previous three years, inflation adjusted. It is sales, not profit, and cosmetic sales specifically.
- No published adjusted figure, and no exemption certificates: you make the judgement and document it yourself.
The exclusions matter more than the threshold, because they are absolute. Make or process any of these four and the exemption is gone whatever your revenue.
| Never exempt | Statutory test | What it catches in this trade |
|---|---|---|
| Eye mucous membrane contact | Regularly comes into contact with the mucous membrane of the eye under customary or usual conditions of use | Cream eyeshadow, brow balm, a cleansing balm sold for eye makeup. An under-eye balm is a genuine grey area, and the wording to argue over is "regularly" and "mucous membrane" |
| Injected products | Product is injected | Nothing a balm maker sells, and a product that is injected is not a cosmetic in the first place |
| Internal use | Intended for internal use | Not balms. Note that a lip product is external even though some of it is swallowed |
| Alters appearance beyond 24 hours | Intended to alter appearance for more than 24 hours where removal by the consumer is not part of customary use | Long-wear stains and semi-permanent colour. A tinted lip balm that wears off through the day is not caught |
Two practical consequences follow. The FDA has published no inflation-adjusted dollar figure and issues no exemption certificates, so nobody confirms your status: you work it out from your own sales records, write down the reasoning and the date, and keep it with the safety file. And lip balms, body balms and salves normally qualify on the product side, so the only live question for most makers is the under-eye case above.
Records, and what "adequate substantiation" looks like for a balm
Safety substantiation is not a certificate you buy. It is a file you keep, and for a simple anhydrous product a careful maker can assemble it honestly. A workable file per formula holds: the formula in weight percent totalling 100; a supplier specification for every raw material; the safety basis for each ingredient, typically the Cosmetic Ingredient Review conclusion; the microbiological reasoning for a water-free product; stability observations from shelf life testing; the finished label; and a dated, signed conclusion.
Adverse event records run six years, or three for a qualifying small business, and a serious adverse event must be reported within 15 business days with the retail label attached. So you need one log, kept from day one, recording every complaint with date, batch, contact details and outcome. This is where voluntary batch coding stops being tidiness, which is why batch scaling and sourcing records belong to the same paperwork habit.
Warnings and the claim boundary
Part 740 requires a warning whenever one is necessary or appropriate to prevent a health hazard, in bold type at least 1/16 inch tall on a contrasting background. Section 740.10 adds a consequence for skipping your homework: a product whose safety has not been adequately substantiated must bear "Warning: The safety of this product has not been determined". That is the label of last resort.
Everything on the label also has to stay inside the cosmetic category. The moment a lip balm carries an SPF number or says it treats anything, it is a drug and needs a Drug Facts panel instead of an ingredient declaration. That boundary is set out in full under cosmetic versus drug claims, and the specific case of sun protection under SPF in lip balm.
A compliance checklist
| Step | Done when |
|---|---|
| 1. Fix the formula in weight percent | It totals 100 and every material has a supplier specification on file |
| 2. Confirm you are a cosmetic | No therapeutic claim anywhere, including your website and social media |
| 3. Build the safety substantiation file | Ingredient safety basis, microbiological reasoning, stability, dated conclusion |
| 4. Write the ingredient declaration | INCI names, descending to one percent, colourants last |
| 5. Lay out the principal display panel | Identity plus net quantity, sized and placed correctly |
| 6. Add business name, address and adverse event contact | Street address with ZIP, plus a contact you actually monitor |
| 7. Decide on warnings | Any hazard specific to your formula is addressed in bold type |
| 8. Test the label on the pack | Type sizes measured on a printed proof, not on screen |
| 9. Check the registration threshold | Either under one million dollars with none of the excluded product types, or registered and listed |
| 10. Open the complaint log | It exists, with a six year retention rule, or three as a small business |
What to do next
Print a proof and measure it. Almost every non-compliant handmade label fails on something physical rather than legal: type below the minimum height, the net quantity crammed into a corner, an ingredient list cut to fit the artwork. Choose the pack first and the label second, which is the argument in the packaging guide, and the reason tube choice belongs in the same decision as filling lip balm tubes.
Then decide deliberately whether you are relying on the small business exemption. It costs nothing to claim and it is fragile: one eye-area product, or one good year, and it disappears. Registration and listing are free and take an afternoon, so a maker approaching the threshold often does it early rather than track the arithmetic. If you also sell across the Atlantic, selling balms in the UK and EU is where that starts. Do not copy a label off a competitor's tube: there is no way to tell from the outside whether they got it right. Start from your own formula and work outwards.
Frequently asked questions
What has to be on a handmade lip balm label in the US?
Five things. On the front: a statement of identity saying what the product is, and the net quantity of contents. Elsewhere on the package: the name and place of business of the manufacturer, packer or distributor; the ingredient declaration in descending order of predominance down to one percent; and, since December 2024, contact information through which the responsible person can receive adverse event reports.
Who qualifies for the MoCRA small business exemption?
Responsible persons and facility owners whose average gross annual United States cosmetic sales for the previous three years are under one million dollars, adjusted for inflation. The exemption covers only two obligations: good manufacturing practice under section 606 and facility registration and product listing under section 607. Safety substantiation, adverse event reporting and labelling still apply to everyone.
Which products are excluded from the small business exemption?
Four categories, listed in the statute. Cosmetic products that regularly come into contact with the mucous membrane of the eye under customary use; products that are injected; products intended for internal use; and products intended to alter appearance for more than 24 hours where removal by the consumer is not part of customary use. Make any of those and you lose the exemption entirely.
Do I have to list ingredients on a tiny lip balm tube?
Yes, but the format flexes. On packages with less than 12 square inches of surface, ingredient type size may drop to one thirty-second of an inch, and for products held in display units the declaration may appear in labelling that accompanies the product rather than on the tube itself. It cannot simply be omitted because the tube is small.
Does the US require a batch code or an expiry date on cosmetics?
Neither is generally required for cosmetics under federal law, unlike the European Union, which requires a batch number and either a minimum durability date or a period after opening. Batch coding is still worth doing voluntarily: without it you cannot trace a complaint back to a pour, and you cannot execute a partial recall.
Do I have to register my kitchen with the FDA?
Only if you are not a small business. Facility registration under MoCRA applies to establishments that manufacture or process cosmetic products distributed in the United States, but a maker under the one million dollar sales threshold who does not make any of the four excluded product types is exempt. Nothing exempts you from the safety substantiation and adverse event duties.
Can states impose their own cosmetic rules?
Partly. MoCRA preempts state requirements that are different from or in addition to federal rules on registration and listing, good manufacturing practice, records, recalls, adverse event reporting and safety substantiation. It expressly preserves state power to prohibit or limit ingredients, and preserves ingredient reporting requirements that were already in force, which is why California's disclosure regime survives.
Sources and further reading
- US Food and Drug Administration, Cosmetics Labeling Guide, Center for Food Safety and Applied Nutrition, February 2022.
- US Code of Federal Regulations, 21 CFR Part 701, Cosmetic labeling, 2024 edition.
- US Code of Federal Regulations, 21 CFR Part 740, Cosmetic product warning statements, 2024 edition.
- US Food and Drug Administration, Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
- US Food and Drug Administration, Registration and Listing of Cosmetic Product Facilities and Products, figures current at 30 June 2026.
- United States Code, 21 U.S.C. 364h, Small businesses.
- United States Code, 21 U.S.C. 364a, Adverse events.
- US Food and Drug Administration, Compliance Policy for Cosmetic Product Facility Registration and Cosmetic Product Listing, Federal Register, 9 November 2023.
Reviewed and updated 6 September 2026. Spotted an error? Tell us and we will fix and log it.